Average cost of drugs for extensively drug-resistant tuberculosis in Malaysia
Malaysia: Average cost of drugs for extensively drug-resistant tuberculosis was 10,000 constant 2022 US$ in 2024. ◆ Volatile
Latest (2024)
10,000 constant 2022 US$
Change on year
unchanged
World rank
4th
of 56 countries
All-time high
45,000 constant 2022 US$
in 2017
All-time low
10,000 constant 2022 US$
in 2022
Years of data
8
2017–2024
Average cost of drugs for extensively drug-resistant tuberculosis in Malaysia, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
The most recent figure for average cost of drugs for extensively drug-resistant tuberculosis in Malaysia is 10,000 constant 2022 US$, measured in 2024. That is the lowest value across all 8 years on record.
That represents a change of down 77.8% over ten years.
Malaysia ranks 4th of 56 countries on this measure, in the top 10%.
Average cost of drugs for extensively drug-resistant tuberculosis in Malaysia, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 45,000 constant 2022 US$ | — |
| 2018 | 45,000 constant 2022 US$ | +0.0% |
| 2019 | 45,000 constant 2022 US$ | +0.0% |
| 2020 | 40,000 constant 2022 US$ | -11.1% |
| 2021 | 40,000 constant 2022 US$ | +0.0% |
| 2022 | 10,000 constant 2022 US$ | -75.0% |
| 2023 | 10,000 constant 2022 US$ | +0.0% |
| 2024 | 10,000 constant 2022 US$ | +0.0% |
Malaysia compared with similar countries
- Malaysia's 10,000 constant 2022 US$ is above the median for upper middle income countries, which is 2,000 constant 2022 US$, 5.0× the median. (23 countries reporting)
- Malaysia's 10,000 constant 2022 US$ is above the median for East Asia & Pacific, which is 1,194 constant 2022 US$, 8.4× the median. (8 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 45,000 constant 2022 US$ | 45,000 constant 2022 US$ | 45,000 constant 2022 US$ | 3 |
| 2020s | 22,000 constant 2022 US$ | 10,000 constant 2022 US$ | 40,000 constant 2022 US$ | 5 |
Countries ranked near Malaysia
More reference data data for Malaysia
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.7102 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 0.5869 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 4.62 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.1487 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 4.62 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 2.38 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 1.64 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 3.29 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 21.1 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 0.8098 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Malaysia?
- Average cost of drugs for extensively drug-resistant tuberculosis in Malaysia was 10,000 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Malaysia?
- The highest recorded value was 45,000 constant 2022 US$ in 2017.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Malaysia?
- The lowest recorded value was 10,000 constant 2022 US$ in 2022.
- How does Malaysia rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Malaysia ranks 4th out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Malaysia?
- Over the last ten years it is down 77.8%. The long-run trend across the full record is volatile.
- Where does this Malaysia data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.